Click the following link to watch video:
https://insider.thomsonreuters.com/link.html?cn=share&cid=1622680&shareToken=MzpiZTg4ZWFlNC0xMzlhLTQ0ZDItYjFiNS02YmM5ZWZkMWZjOGU%3D&playerName=ReutersNews
Source: Thomson Reuters
Description: Valeant shares tumble in premarket after the
drugmaker reported disappointing first-quarter
profit. Lotte and Hanwha Chemical eye U.S. buys to
boost growth.
(To access all exclusive Reuters Insider programming visit: http://insider.thomsonreuters.com)
Short Link: http://reut.rs/1YcBHh0
Transcript (May be auto-generated)
Good morning. Wall Street seems to have a drug problem this morning. Shares in
Valeant tumbling almost 11% in pre-market. The troubled Canadian drugmaker
disappointed investors by reporting lower-than-expected first-quarter profit.
The company also slashed its full-year sales and adjusted profit guidance for a
second time this year. Behind the weakness, challenges within its dermatology
department. The company, which is also in the spotlight for its business and
accounting practices, says it will now file its results in a timely manner. And
Alexion also tumbling 11% after its drug Soliris missed a main goal in its
study. But Sarepta Therapeutics soaring 37% after the FDA asked for more
information on its muscle-wasting treatment. That's raising hopes it could be
improved. In other business news, IBM says it inked a $300 million deal with
Dubai's Emirates Airline. The agreement means IBM will provide the airline IT
services for 10 years, which will help Emirates improve the efficiency on its
passenger support systems. Verizon's set to submit a bid of around $3 billion
for Yahoo's core internet business - that's according to the Wall Street
Journal.
Citing people close to the matter, the newspaper said private equity firm TPG is
also seen submitting a second round bid. Watch this space. And staying with M&A,
Lotte Chemical, Hanwha, and Hanwha Chemical are eyeing up US companies. Asian
chemical companies are flush with cash as plunging oil prices slashed their cost
base. So many are now looking for assets to boost growth. Lotte Chemical is
bidding for Axiall, while Hanwha has submitted a letter of intent to buy.
Let's take a look at how Wall Street might open after Fed Chair Janet Yellen
basically killed off talk of a June rate hike. Yellen said last month's jobs
report was disappointing and bears watching. She also added that further gradual
rises in rates are likely to be appropriate but stopped short of giving a
time-frame. All that is giving futures a lift. The Dow Jones, the S&P, and the
Nasdaq are mostly higher. And that's today's morning call. I'm Jade Barker and
this is Reuters